Andreas Halvorsen - Viking Global Investors
Holding/activity history for Teva Pharmaceutical Industries Ltd. (TEVA)
← All TEVA superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | 0 | 0.00 | Sell 100.00% | 0.13 | $20.11–34.11 · VW $29.43i | SEC | |
| 2025 Q3 | 2,532,119 | 0.13 | Reduce 78.32% | 0.45 | $14.99–20.71 · VW $18.73i | $51,148,804 | SEC |
| 2025 Q2 | 11,681,333 | 0.57 | Add 15.37% | 0.08 | $15.38–18.30 · VW $16.38i | $195,779,141 | SEC |
| 2025 Q1 | 10,125,478 | 0.49 | Add 55.69% | 0.18 | $12.47–17.75 · VW $15.24i | $155,628,597 | SEC |
| 2024 Q4 | 6,503,485 | 0.46 | Reduce 14.06% | 0.07 | $16.15–22.80 · VW $18.89i | $143,336,809 | SEC |
| 2024 Q3 | 7,567,533 | 0.50 | Buy | 0.50 | $15.81–19.08 · VW $17.78i | $136,366,945 | SEC |
| 2016 Q4 | 0 | 0.00 | Sell 100.00% | 4.01 | $32.11–44.13 · VW $36.56i | SEC | |
| 2016 Q3 | 19,684,219 | 4.01 | Reduce 29.03% | 1.74 | $41.67–55.79 · VW $46.73i | $905,671,000 | SEC |
| 2016 Q2 | 27,736,655 | 6.00 | Reduce 15.88% | 1.25 | $48.01–56.44 · VW $52.65i | $1,393,212,000 | SEC |
| 2016 Q1 | 32,971,622 | 7.88 | Add 31.66% | 1.89 | $52.62–62.80 · VW $56.62i | $1,764,311,000 | SEC |
| 2015 Q4 | 25,043,775 | 6.54 | Add 182.26% | 4.22 | $57.41–66.55 · VW $61.81i | $1,643,873,000 | SEC |
| 2015 Q3 | 8,872,650 | 2.08 | Buy | 2.08 | $54.17–71.68 · VW $61.68i | $500,950,000 | SEC |
| 2015 Q2 | 0 | 0.00 | Sell 100.00% | 0.06 | $58.47–72.31 · VW $66.60i | SEC | |
| 2015 Q1 | 228,600 | 0.06 | Buy | 0.06 | $55.22–68.75 · VW $61.46i | $14,242,000 | SEC |
Price snapshot:
Current price$32.18
52-week low$14.99
52-week high$37.35